-
1Academic Journal
المؤلفون: Ekta Agrawal, Ashish K Gautam, Abdur Rahaman Shaikh, Souvik Dutta, Samit Dey, Shyamal K Mukherjee, Sangita Saha, Sanjukta Mandal, Shubhamoy Ghosh, Munmun Koley, Subhranil Saha
المصدر: Journal of Dermatology and Dermatologic Surgery, Vol 25, Iss 2, Pp 102-113 (2021)
مصطلحات موضوعية: atopic dermatitis, bengali language, quality of life, reliability, validity, Dermatology, RL1-803
وصف الملف: electronic resource
-
2
المؤلفون: Priyanka Ghosh, Subhasish Ganguly, Shyamal Kumar Mukherjee, Souvik Dutta, Abdur Rahaman Shaikh, Sk Swaif Ali, Navin Kumar Singh, Pulakendu Bhattacharya, Munmun Koley, Subhranil Saha
المصدر: Homeopathy. 112:085-096
مصطلحات موضوعية: Complementary and alternative medicine
-
3
المؤلفون: Munmun Koley, Subhasish Ganguly, Priyanka Ghosh, Subhranil Saha, Satarupa Sadhukhan, Shyamal Kumar Mukherjee, Sk Swaif Ali, Souvik Dutta, Pallavi Hazra, Abdur Rahaman Shaikh, Aniket Singha Roy
المصدر: EXPLORE. 18:279-286
مصطلحات موضوعية: medicine.medical_specialty, Placebo-controlled study, Context (language use), 030204 cardiovascular system & hematology, Placebo, Prehypertension, law.invention, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, medicine, Humans, 030212 general & internal medicine, Adverse effect, General Nursing, business.industry, Homeopathy, Treatment Outcome, Blood pressure, Complementary and alternative medicine, Hypertension, Materia Medica, Chiropractics, business, Analysis
-
4
المؤلفون: Satarupa Sadhukhan, Ashish Kumar Gautam, Abdur Rahaman Shaikh, Munmun Koley, Sangita Saha, Sk Swaif Ali, Anamika Basu, Samit Dey, Ekta Agrawal, Avaranjika Karuppusamy, Souvik Dutta, Subhranil Saha
المصدر: Complementary Medicine Research. 29:17-26
مصطلحات موضوعية: Adult, medicine.medical_specialty, Randomization, business.industry, Common cold, Homeopathy, Atopic dermatitis, Placebo, medicine.disease, Dermatitis, Atopic, law.invention, Treatment Outcome, Double-Blind Method, Complementary and alternative medicine, Randomized controlled trial, law, Internal medicine, Materia Medica, Clinical endpoint, medicine, Humans, Adverse effect, business